Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Febrile Neutropenia × Meropenem × Clear all

Phase

Phase 4 4 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Other Infectious Diseases 1 Neoplasms 1 Hematologic Neoplasms 1 Febrile Neutropenia 1

Interventions

pegylated granulocyte colony-stimulating factor 3 Interleukin 1 Receptor Antagonist Protein 2 Filgrastim 2 pegfilgrastim 1 Vancomycin 1 Piperacillin, Tazobactam Drug Combination 1 Meropenem 1 Linezolid 1 Cefepime 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02732327 2017-07-21

Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer

Forest Laboratories

Phase 2 Terminated

2 enrolled 2 charts

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡